ABSTRACT: Hantavirus Pulmonary Syndrome (HPS), a severe and frequently fatal respiratory disease, was first recognized in 1993 during an outbreak of acute illness in the Four Corners area of the southwestern United States. The etiologic agent, Sin Nombre virus (SNV), was identified as a previously unrecognized member of the Hantavirus genus transmitted by rodents, especially members of the genus Peromyscus, which shed SNV in urine and feces. Since 1993, 16 California residents have been diagnosed with HPS, four of these were identified retrospectively with onset prior to 1993. The median age of case-patients was 42 years, 10 were male, and eight died. Sites of likely exposure for these cases tended to cluster in the eastern Sierra Nevada range. Serologic surveillance of rodents has been conducted prospectively in California since 1993 and retrospectively for specimens collected back to 1975. To date, serologic evidence of infection with SNV has been recognized in 473 (6.6%) of 7,191 rodents from 18 genera, and in 426 (9.6%) of 4,489 Peromyscus spp. At least one seroreactive Peromyscus sp. specimen has been identified in 40 of 46 counties surveyed.
INTRODUCTION
Hantavirus pulmonary syndrome (HPS) was first recognized in 1993 when an outbreak of an acute illness of unknown etiology occurred among residents of the Four Corners area in the southwestern United States (CDC 1994) . The illness was characterized by a prodrome of fever and flu-like symptoms which rapidly progressed to respiratory distress and was frequently fatal. The etiologic agent was identified as a previously unrecognized member of the Hantavirus genus that was given the provisional name of Sin Nombre virus (SNV). Rodents, especially members of the genus Peromyscus, were identified as the principal reservoir of the virus, which they shed in urine and feces.
Since 1993, the California Department of Health Services, in cooperation with local health agencies and vector control programs, has conducted surveillance for hantavirus in human and non-human mammals in California.
This report summarizes results of this surveillance from 1993 to 1997.
METHODS

HPS Cases
Passive surveillance for HPS cases is conducted through the Division of Communicable Disease Control of the California Department of Health Services (DHS). Serologic testing of suspect HPS patients is provided through the Viral and Rickettsial Diseases Laboratory (VRDL), DHS. A suspect HPS case is defined as a previously healthy patient experiencing a febrile illness (i.e., temperature greater than 101° F) characterized by bilateral diffuse interstitial edema that may radiographically resemble adult respiratory distresss syndrome, with respiratory compromise requiring supplemental oxygen, developing within 72 hours of hospitalization (CDC 1998) . California health care providers desiring serologic testing of a suspect HPS case are requested to submit 5 to 10 ml of acute whole blood to the VRDL. An immunofluorescent antibody procedure with SNV antigen is used for testing for hantavirus antibody activity in serum specimens. An attempt is made to obtain a convalescent blood sample on all patients for whom the acute specimen was reactive. For fatal cases, specimens of lung and kidney tissue are requested. Information on the suspect patient's acute illness is collected in the case history form which accompanies the serologic specimen and, in the event of a confirmed case, through detailed abstraction of the complete medical record. Information on the patient's work-related and recreational activities, place of residence, and recent travel are collected from the patient or a proxy to assist in determining the likely circumstances of exposure. Onsite investigations of the patient's residence and other likely exposure locales are conducted by public health biologists and environmental health specialists from the state and local health departments.
Rodent Surveillance
As part of the environmental follow-up conducted on all confirmed HPS cases in California, attempts are made to collect blood from rodents at each potential exposure site. Procedures and total trap-nights vary according to the suspected circumstances of the patient's exposure (e.g., occupational versus peridomestic) and the interval between confirmation of the case and initiation of the environmental follow-up. Blood samples are obtained from collected rodents by intracardiac puncture using a 1 ml. tuberculin hypodermic needle. Blood samples are chilled and shipped on ice to VRDL for processing. Serologic testing is conducted as previously described (Jay et al. 1997) . Specimens with antibody activity detectable at a dilution of 1:64 or greater are considered reactive.
In addition to responsive surveillance, since 1993 DHS and other agencies have routinely collected serum specimens for hantavirus evaluation from rodents throughout California. Also, selected archived specimens, including sera, tissues, and whole carcasses, from rodents collected in California back to 1975 have been tested for evidence of hantavirus infection.
RESULTS AND DISCUSSION HPS cases
Since 1993, 16 California residents have been diagnosed with HPS (Table 1) . Four of these were identified retrospectively, with onset of illness having occurred in 1980, 1984, and two in 1992. Eight cases had a fatal outcome. The median age of case-patients was 42 years (range, 22 to 56) and 10 were male. Casepatients were residents of 11 counties-Alameda, Contra Costa, Inyo (2), Kern, Modoc, Mono (4), Nevada (2), Plumas, Santa Barbara, San Bernardino, and San Francisco (Figure 1 ). Probable sites of exposure included the counties of Inyo (2), Modoc, Mono (4 or 5), Nevada (2), Placer, Plumas, and Santa Barbara, and the states of New Mexico (2) and Washington. Probable exposure site could not be reliably determined for one case.
The circumstances of exposure were peridomestic for seven cases, occupational for four, recreational for three, and unknown for two. Detailed clinical and epidemiologic features of select California HPS cases have been previously described (Flood et al. 1995; Schwarcz et al. 1996; Shefer et al. 1994; Jay et al. 1996) .
Rodent Surveillance
Testing for hantavirus seroreactivity in California mammals has been performed on specimens from 7,295 animals, representing 51 species of 27 genera. Among the 18 genera of rodents evaluated, evidence of hantavirus seroreactivity has been identified in seven (Table 2) . Six species of the genus Peromyscus have demonstrated the most consistent seroreactivity; 426 (9.6%) of 4,489 Peromyscus spp. tested had detectable antibody to SNV (Table 3) . At least one seroreactive Peromyscus specimen has been identified in 40 of 46 counties sampled ( Figure  1 ). Vista, respectively) , but these strain variations have not been shown to be pathogenic to humans. Seroreactivity has been occasionally identified in Neotoma sp., Perognathus sp., and Spermophilus sp. rodents in California and elsewhere; however, it is believed that these species are incidentally infected with SNV and are not competent reservoirs or vectors.
Reithrodontomys megalotis and
There is no serologic evidence to date of SNV infection in domestic rodent species (i.e., Mus spp., Rattus spp.), lagomorphs, or wild and domestic carnivores. 'Counties in which surveillance for hantavirus in rodents has yet to be conducted are not listed.
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